Brimonidine Tartrate for the Treatment of Injection Related Erythema
Status:
Withdrawn
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the Injection Related Erythema (IRE)
mitigation effect of a single administration of brimonidine tartrate in comparison with a
vehicle gel (placebo).
The secondary study objectives are to evaluate the IRE mitigation effect of a single
administration of brimonidine tartrate in comparison with a vehicle gel on a more stringent
definition scale, in accordance with the primary endpoint of the original brimonidine pivotal
trials and participants' satisfaction with the overall appearance of their skin.